Precision Medicine News and Research

RSS

Evosep launches new separation technology tailored for clinical omics at HUPO 2017

Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. We will make sample preparation and separation for mass spectrometry analysis 100 times more robust and 10 times faster to enable truly large cohort studies and provide the foundation for precision medicine.

From Evosep 19 Sep 2017

Scientists discover markers for progressive multiple sclerosis

Scientists have uncovered two closely related cytokines -- molecules involved in cell communication and movement -- that may explain why some people develop progressive multiple sclerosis (MS), the most severe form of the disease.

18 Sep 2017

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions.

18 Sep 2017

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.

18 Sep 2017

Myriad Genetics presents positive results of new hereditary cancer test at 36th annual conference of NSGC

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations at the 36th annual conference of the National Society of Genetic Counselors in Columbus, OH.

18 Sep 2017

BC Platforms introduces new resource that enables integrated analytics of genomic and clinical data

BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data.

14 Sep 2017

FDA moves to guard against abuse of ‘orphan drug’ program

The Food and Drug Administration is changing the way it approves medicines known as "orphan drugs" after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.

13 Sep 2017

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.

12 Sep 2017

Study provides new insights into biologic networks involved in IBD

Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions today published results of an in-depth, multi-omics approach to characterizing the immune component of inflammatory bowel disease (IBD).

11 Sep 2017

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, is working to educate the public about hereditary cancer risk assessment and testing during Prostate Cancer Awareness Month this September.

11 Sep 2017

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the ARIEL3 trial reported today at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Median Technologies to exhibit its imaging solutions and services at ESMO 2017 Congress

Median Technologies, the Imaging Phenomics Company, announced today that it will be exhibiting at the ESMO 2017 Congress, September 8-12 at IFEMA, Feria de Madrid, Spain

8 Sep 2017

Researchers reveal new approach to precisely identify and treat prostate cancer

Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects.

7 Sep 2017

Myriad Genetics introduces new precision medicine tool to enhance myRisk Hereditary Cancer test

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test. riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.

7 Sep 2017

Structural abnormalities in the brain's white matter seen in children with ASD traits

Structural abnormalities in the brain's white matter match up consistently with the severity of autistic symptoms not only in children with autism spectrum disorder (ASD), but also, to some degree, in those with attention-deficit/hyperactivity disorder (ADHD) who also have autistic traits.

6 Sep 2017

Combined PET/CT scanning could identify melanoma patients' response to ICI therapy

Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.

6 Sep 2017

Antidepressants used for chronic pain relief come with significant side effects

Chronic pain negatively impacts a person's quality of life. Often, over the counter pain medication, such as ibuprofen or aspirin, are ineffective in alleviating chronic pain. In these instances, a surprising choice is often a drug used to treat an entirely different condition - depression.

5 Sep 2017

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

The Southeast's first comprehensive cancer treatment program at the University of Alabama at Birmingham takes patient care to the next level by improving the lives of women affected by or at risk for ovarian cancer.

31 Aug 2017

Researchers provide approaches to optimize cardiovascular risk reduction for patients with SAMS

Statins are highly effective for preventing heart attacks by reducing low-density lipoprotein or "bad" cholesterol.

29 Aug 2017

UA College of Medicine - Tucson selected for NIH initiative to advance critical emergency medicine research

The University of Arizona College of Medicine - Tucson is one of a team of six national institutions selected for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network, a new initiative of the National Institutes of Health to advance critical emergency medicine research.

26 Aug 2017

Precision Medicine News and Research

Evosep launches new separation technology tailored for clinical omics at HUPO 2017

Scientists discover markers for progressive multiple sclerosis

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Myriad Genetics presents positive results of new hereditary cancer test at 36th annual conference of NSGC

BC Platforms introduces new resource that enables integrated analytics of genomic and clinical data

FDA moves to guard against abuse of ‘orphan drug’ program

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Study provides new insights into biologic networks involved in IBD

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Median Technologies to exhibit its imaging solutions and services at ESMO 2017 Congress

Researchers reveal new approach to precisely identify and treat prostate cancer

Myriad Genetics introduces new precision medicine tool to enhance myRisk Hereditary Cancer test

Structural abnormalities in the brain's white matter seen in children with ASD traits

Combined PET/CT scanning could identify melanoma patients' response to ICI therapy

Antidepressants used for chronic pain relief come with significant side effects

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

Researchers provide approaches to optimize cardiovascular risk reduction for patients with SAMS

UA College of Medicine - Tucson selected for NIH initiative to advance critical emergency medicine research

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News